Alivus Life Sciences Ltd (ALIVUS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003513,
    "name": "Alivus Life",
    "stock_name": "Alivus Life",
    "full_name": "Alivus Life Sciences Ltd",
    "name_url": "stocks-analysis/alivus-life",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "943.90",
    "chg": 23.1,
    "chgp": "2.51%",
    "dir": 1,
    "prev_price": "920.80",
    "mcapval": "11,591.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543322,
    "symbol": "ALIVUS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE03Q201024",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "61.77 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/alivus-life-1003513-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alivus Life Sciences Faces Bearish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-faces-bearish-momentum-amid-technical-downturn-3743041",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AlivusLifeScien_technicaldot_3743041.png",
        "date": "2025-12-03 08:08:57",
        "description": "Alivus Life Sciences, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in price momentum as reflected by recent technical indicators. The stock’s movement over the past weeks and months reveals a cautious market stance, with several technical parameters signalling a bearish trend. This article analyses the evolving technical landscape of Alivus Life Sciences and places its performance in the context of broader market movements."
      },
      {
        "title": "Alivus Life Sciences Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-technical-momentum-shifts-amid-mixed-market-signals-3740410",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AlivusLifeScien_technicaldot_3740410.png",
        "date": "2025-12-02 08:12:19",
        "description": "Alivus Life Sciences, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments reveal a transition from a bearish to a mildly bearish trend, underscoring nuanced changes in price dynamics and technical indicators that investors should carefully consider."
      },
      {
        "title": "Alivus Life Sees Revision in Market Assessment Amidst Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-downgraded-to-sell-by-marketsmojo-amid-weak-financial-trends-3733129",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AlivusLife_mojoScore_3733129.png",
        "date": "2025-11-27 10:06:18",
        "description": "Alivus Life, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent performance trends and sector dynamics. The company’s assessment metrics have been adjusted following a period of subdued financial growth and technical indicators signalling caution."
      },
      {
        "title": "Why is Alivus Life falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-alivus-life-fallingrising-3727145",
        "imagepath": "",
        "date": "2025-11-25 01:43:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Comparison</strong></p>\n<p>Alivus Life’s stock has experienced a notable decline over the past week, falling by 5.22%, significantly underperforming the Sensex, which remained nearly flat with a marginal 0.06% gain. Over the last month, the stock also declined by 2.90%, while the Sensex advanced by 0.82%. Year-to-date, the stock has lost 9.28% of its value, contrasting sharply with the Sensex’s 8.65% gain. The disparity is even more pronounced over the last year, with Alivus Life posting a negative return of 14.46% against the Sensex’s positive 7.31%.</p>\n<p>These figures highlight a persistent underperformance trend, suggesting that investors have been cautious about the stock amid broader market gains. Despite the company’s impressive three-year return o..."
      },
      {
        "title": "Alivus Life Sciences Faces Bearish Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-faces-bearish-momentum-amid-technical-downturn-3723903",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AlivusLifeScien_technicaldot_3723903.png",
        "date": "2025-11-24 08:06:04",
        "description": "Alivus Life Sciences, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in price momentum with technical indicators signalling a predominantly bearish trend. Recent market data reveals a nuanced picture of the stock’s performance, highlighting challenges amid broader sector dynamics and market conditions."
      },
      {
        "title": "Is Alivus Life technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-alivus-life-technically-bullish-or-bearish-3710374",
        "imagepath": "",
        "date": "2025-11-18 08:32:54",
        "description": "As of 17 November 2025, the technical trend has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the weekly MACD indicating bearish momentum and the daily moving averages also reflecting a mildly bearish outlook. The weekly Bollinger Bands support this view with a mildly bearish signal, while the monthly indicators show a mixed picture with the KST and Dow Theory both indicating mild bullishness, but overall, the monthly MACD and moving averages remain mildly bearish. The lack of strong signals from the RSI and OBV further suggests a lack of clear bullish momentum...."
      },
      {
        "title": "Alivus Life Sciences Faces Technical Trend Shifts Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-price-increase-3710687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AlivusLifeScien_technicaldot_3710687.png",
        "date": "2025-11-18 08:23:04",
        "description": "Alivus Life Sciences, a small-cap in the Pharmaceuticals and Biotechnology sector, has recently revised its evaluation amid market dynamics. The stock has shown resilience over three years with a significant return, although its one-year performance contrasts with the Sensex. Ongoing performance monitoring remains crucial in this competitive landscape."
      },
      {
        "title": "Why is Alivus Life falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-alivus-life-fallingrising-3709405",
        "imagepath": "",
        "date": "2025-11-17 23:50:22",
        "description": "As of 17-Nov, Alivus Life Sciences Ltd is experiencing a price increase, currently at 945.40, which reflects a rise of 41.05 or 4.54%. The stock has shown positive momentum, gaining 4.67% over the last two days and outperforming its sector by 4.26% today. Despite this recent uptick, the stock has underperformed over the past year, with a return of -11.99%, while its profits have increased by 25.2%. The company maintains a high management efficiency with a return on equity (ROE) of 18.73% and a low debt-to-equity ratio, which contributes positively to its valuation. However, the stock is trading at a premium compared to its peers, and its long-term growth prospects appear weak, with net sales and operating profit growing at only 4.84% and 2.21% annually over the last five years, respectively.\n\nIn the broader market context, Alivus Life's short-term performance has outpaced the Sensex, which has returned 1.69..."
      },
      {
        "title": "Is Alivus Life technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-alivus-life-technically-bullish-or-bearish-3700381",
        "imagepath": "",
        "date": "2025-11-14 08:13:19",
        "description": "As of 13 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include the weekly MACD and Bollinger Bands both signaling bearish conditions, along with daily moving averages also indicating a bearish trend. The monthly MACD is mildly bearish, and the Dow Theory shows a mildly bearish stance as well. Although the KST shows mild bullishness on the weekly timeframe, it is outweighed by the overall bearish signals across other indicators...."
      }
    ],
    "total": 238,
    "sid": "1003513",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/alivus-life-sciences-1003513"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "02-Feb-2026",
      "details": "Kindly refer enclosed attachment.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "30-Jan-2026",
      "details": "Please find enclosed herewith transcript of Earnings Call held on 22nd January 2026 which is also made available on the website of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "30-Jan-2026",
      "details": "Kindly refer the attachment.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 25",
          "dt": "2025-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alivus Life Sciences Faces Bearish Momentum Amid Technical Shifts

2025-12-03 08:08:57

Alivus Life Sciences, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in price momentum as reflected by recent technical indicators. The stock’s movement over the past weeks and months reveals a cautious market stance, with several technical parameters signalling a bearish trend. This article analyses the evolving technical landscape of Alivus Life Sciences and places its performance in the context of broader market movements.

Alivus Life Sciences Technical Momentum Shifts Amid Mixed Market Signals

2025-12-02 08:12:19

Alivus Life Sciences, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments reveal a transition from a bearish to a mildly bearish trend, underscoring nuanced changes in price dynamics and technical indicators that investors should carefully consider.

Alivus Life Sees Revision in Market Assessment Amidst Sector Challenges

2025-11-27 10:06:18

Alivus Life, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent performance trends and sector dynamics. The company’s assessment metrics have been adjusted following a period of subdued financial growth and technical indicators signalling caution.

Why is Alivus Life falling/rising?

2025-11-25 01:43:41

Recent Price Performance and Market Comparison Alivus Life’s stock has experienced a notable decline over the past week, falling by 5.22%, significantly underperforming the Sensex, which remained nearly flat with a marginal 0.06% gain. Over the last month, the stock also declined by 2.90%, while the Sensex advanced by 0.82%. Year-to-date, the stock has lost 9.28% of its value, contrasting sharply with the Sensex’s 8.65% gain. The disparity is even more pronounced over the last year, with Alivus Life posting a negative return of 14.46% against the Sensex’s positive 7.31%. These figures highlight a persistent underperformance trend, suggesting that investors have been cautious about the stock amid broader market gains. Despite the company’s impressive three-year return o...

Alivus Life Sciences Faces Bearish Momentum Amid Mixed Technical Signals

2025-11-24 08:06:04

Alivus Life Sciences, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in price momentum with technical indicators signalling a predominantly bearish trend. Recent market data reveals a nuanced picture of the stock’s performance, highlighting challenges amid broader sector dynamics and market conditions.

Is Alivus Life technically bullish or bearish?

2025-11-18 08:32:54

As of 17 November 2025, the technical trend has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the weekly MACD indicating bearish momentum and the daily moving averages also reflecting a mildly bearish outlook. The weekly Bollinger Bands support this view with a mildly bearish signal, while the monthly indicators show a mixed picture with the KST and Dow Theory both indicating mild bullishness, but overall, the monthly MACD and moving averages remain mildly bearish. The lack of strong signals from the RSI and OBV further suggests a lack of clear bullish momentum....

Alivus Life Sciences Faces Technical Trend Shifts Amid Market Evaluation Revision

2025-11-18 08:23:04

Alivus Life Sciences, a small-cap in the Pharmaceuticals and Biotechnology sector, has recently revised its evaluation amid market dynamics. The stock has shown resilience over three years with a significant return, although its one-year performance contrasts with the Sensex. Ongoing performance monitoring remains crucial in this competitive landscape.

Why is Alivus Life falling/rising?

2025-11-17 23:50:22

As of 17-Nov, Alivus Life Sciences Ltd is experiencing a price increase, currently at 945.40, which reflects a rise of 41.05 or 4.54%. The stock has shown positive momentum, gaining 4.67% over the last two days and outperforming its sector by 4.26% today. Despite this recent uptick, the stock has underperformed over the past year, with a return of -11.99%, while its profits have increased by 25.2%. The company maintains a high management efficiency with a return on equity (ROE) of 18.73% and a low debt-to-equity ratio, which contributes positively to its valuation. However, the stock is trading at a premium compared to its peers, and its long-term growth prospects appear weak, with net sales and operating profit growing at only 4.84% and 2.21% annually over the last five years, respectively. In the broader market context, Alivus Life's short-term performance has outpaced the Sensex, which has returned 1.69...

Is Alivus Life technically bullish or bearish?

2025-11-14 08:13:19

As of 13 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include the weekly MACD and Bollinger Bands both signaling bearish conditions, along with daily moving averages also indicating a bearish trend. The monthly MACD is mildly bearish, and the Dow Theory shows a mildly bearish stance as well. Although the KST shows mild bullishness on the weekly timeframe, it is outweighed by the overall bearish signals across other indicators....

View All News